Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment

Caporro M, Disanto G, Gobbi C, Zecca C

Patient Preference and Adherence 2014, 8:1123-1134

Published Date: 21 August 2014